Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. Contents
3. Definitions
4. Rationale for concern about MDR-TB
5. Drug resistance increases, treatment success fall
6. Managing a severe epidemic of resistance
7. The size & distribution of the MDR-TB epidemic
8. The global burden of TB 2010
9. Distribution of MDR among new TB cases
10. Distribution of MDR among previously treated TB
11. Estimated MDR-TB incidence rates, 2009
12. Highest % of MDR-TB among new cases
13. Time trends in TB and MDR-TB
14. Countries that reported XDR-TB by end Mar. 2011
15. Global strategies, plans and implementation
16. MDR & XDR- TB control strategic challenges
17. Indicators for PMDT
18. Funding increase but lower than planned
19. MDR-TB notified, projected & global targets
20. MDR-TB treatment enrolment targets 2011
21. DST coverage in 2010
22. Treatment success
23. National level planning and implementation
24. Guidance for MDR-TB management programmes
25. Why plan MDR-TB treatment programmes?
26. Essential principles of care for MDR-TB
27. Essential elements in planning TB control
28. Specific recommendations for PMDT (1)
29. Specific recommendations for PMDT (2)
30. Specific recommendations for PMDT (3)
31. Specific recommendations for PMDT (4)
32. Research gaps
33. Obstacles to MDR-TB management
34. Only few MDR-TB cases are diagnosed & treated
35. Conclusions
36. Policy background
37. References (1)
38. References (2)
39. Acknowledgements

Topics Covered

• Definition of common terms
• The rationale for addressing drug resistance
• The size and distribution of the drug resistance epidemic in TB
• Global level plans for addressing it
• National level plans and implementation
• Obstacles and conclusions
• Sources for further study of the policy background

Links

Series:

• Tuberculosis

Categories:

• Microbiology

Therapeutic Areas:

• Infectious Diseases
• Respiratory Diseases

Talk Citation

Nunn, P. (2013, February 28). Drug resistance in tuberculosis and its public health management [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/BHED7728.
Export Citation (RIS)

Publication History

• Published on February 28, 2013
• Archived on November 28, 2021

Financial Disclosures

• Dr. Paul Nunn has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.